FDA Update: Philips Recalls Tack Endovascular Systems

Mar 06, 2025

The U.S. Food and Drug Administration (FDA) announced on March 3 that Philips is removing and discontinuing distribution of the Tack Endovascular System due to challenges necessitating additional procedures to retrieve or remove the implant.

Keywords: United States Food and Drug Administration, Prostheses and Implants, ACC Advocacy

Sex-Based Analysis of Short-Term DAPT in Patients at High Bleeding Risk Undergoing PCI

Mar 05, 2025

One- and three-month dual antiplatelet therapy (DAPT) was found to have similar risk for ischemic events in both women and men at high bleeding risk undergoing PCI...

Clinical Topics: Invasive Cardiovascular Angiography and Intervention

Keywords: Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Hemorrhage

DAPA-HF and DELIVER: Does Dapagliflozin Reduce Risk For Patients With Severe HF?

Mar 05, 2025

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF...

Clinical Topics: Heart Failure and Cardiomyopathies

Keywords: Sodium-Glucose Transporter 2 Inhibitors, Cardiomyopathies, Ventricular Dysfunction, Left

Amyloidosis Forum: Imaging Endpoints in AL and ATTR Amyloidosis Clinical Trials

Mar 05, 2025

A new state-of-the-art review published March 5 in JACC: Cardiovascular Imaging summarizes a discussion by the Amyloidosis Forum on the role of imaging biomarkers as trial endpoints in the diagnosis and assessment of systemic immunoglobin light...

Clinical Topics: Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Interventions and Imaging, Computed Tomography, Echocardiography/Ultrasound, Nuclear Imaging more

Keywords: Magnetic Resonance Spectroscopy, Biomarkers, Echocardiography, Single Photon Emission Computed Tomography Computed Tomography, Tomography, Emission-Computed, Single-Photon, Amyloid Neuropathies, Familial, Amyloidosis, Familial, Positron Emission Tomography Computed Tomography, Tomography, X-Ray Computed, United States Food and Drug Administration more

What is the Cardiopulmonary Fitness Level of Children With Inherited Cardiac Disease?

Mar 05, 2025

Cardiopulmonary fitness and physical activity levels were significantly lower in children with inherited cardiac disease than in healthy controls, according to a study published Feb. 25...

Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Exercise more

Keywords: Cardiac Arrhythmias, Arrhythmias, Cardiac, Heart Diseases, Cardiomyopathies, Exercise more

ANDROMEDA Meta-Analysis: PCB Angioplasty vs. DES Implantation

Mar 05, 2025

In patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major adverse cardiac events (MACE) ...

Clinical Topics: Invasive Cardiovascular Angiography and Intervention, Atherosclerotic Disease (CAD/PAD), Interventions and Coronary Artery Disease

Keywords: Percutaneous Coronary Intervention, Coronary Artery Disease, Drug-Eluting Stents, Angioplasty, Balloon, Coronary more

Does Tafamidis Improve Survival For Octogenarians With Wild-Type Transthyretin Cardiac Amyloidosis?

Mar 05, 2025

Tafamidis treatment in octogenarians diagnosed with wild-type transthyretin cardiomyopathy (ATTRwt-CM) improves survival without age affecting treatment efficacy, although mortality remains considerable, according to an international cohort study...

Clinical Topics: Geriatric Cardiology, Heart Failure and Cardiomyopathies

Keywords: Geriatric Assessment, Cohort Studies, Aged, 80 and over, Cardiomyopathies, Amyloidosis more

FINEARTS-HF Analysis Shows Finerenone Reduces Worsening HF Symptoms in Outpatients

Mar 05, 2025

Patients with heart failure (HF) who have worsening HF symptoms that require intensification of oral diuretics in the outpatient setting are common and associated with a poor prognosis, and finerenone reduced the need for intensifying diuretics...

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure

Keywords: Heart Failure, Mineralocorticoid Receptor Antagonists, Diuretics

Identifying MI after PCI; Myocardial Fibrosis & Severe Aortic Valve Stenosis; Anticoagulation & Cancer Diagnoses

Mar 05, 2025   |  Kim A. Eagle, MD, MACC

In this week’s View, Dr. Eagle looks at the optimal threshold for identifying a myocardial infarction (MI) after PCI.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Stable Ischemic Heart Disease, Valvular Heart Disease, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Chronic Angina, Vascular Medicine more

Keywords: Non-ST Elevated Myocardial Infarction, Percutaneous Coronary Intervention, Aortic Valve Stenosis, Fibrosis, Cardiomyopathies, Atrial Fibrillation, Neoplasms, Anticoagulants more

Non-Pharmacologic Therapies to Reduce Morbidity, Improve Function of Patients With HF

Mar 04, 2025

A recent State-of-the-Art Review published in JACC: Heart Failure provides evidence-based recommendations on how to best optimize the care of patients with heart failure (HF) through non-pharmacological strategies...

Clinical Topics: Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Diet, Exercise more

Keywords: Life Style, Quality of Life, Heart Failure, Diet, Exercise more